Balchem Corporation Unveils Study Supporting Iron Levels in Blood Donors
Balchem Corporation announced findings from the FORTE Study, which supports iron levels in low-ferritin whole blood donors. This study highlights the need for a steady blood supply, as blood cannot be synthetically produced and has a limited shelf life. The timing of the study's presentation was not specified. The news was generated by Public Technologies using AI and is for informational purposes only.
Balchem Corporation announced findings from the FORTE Study, which examined support for iron levels in low-ferritin whole blood donors. The study addresses the ongoing need for a steady blood supply, given that blood cannot be synthetically produced and has a limited shelf life. Details regarding the timing of the presentation of the study results were not specified. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Balchem Corporation published the original content used to generate this news brief on December 04, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
